Studies on mice have shown that the Smad Ubiquitin Regulatory Factor-1 (SMURF1) gene negatively regulates osteoblast function and the response to bone morphogenetic protein in a dose-dependent fashion (Chan et al. in Mol Cell Biol 27(16):5776–5789, https://doi.org/10.1128/MCB.00218-07, 2007; Yamashita et al. in Cell 121(1):101–113, https://doi.org/10.1016/j.cell.2005.01.035, 2005). In addition, a tumorigenic role for SMURF1 has been implicated due to the interference with apoptosis signals (Nie et al. in J Biol Chem 285(30):22818–22830, https://doi.org/10.1074/jbc.M110.126920, 2010; Wang et al. in Nat Commun 5:4901, https://doi.org/10.1038/ncomms5901, 2014). A 10-year-old girl with a history of severe developmental delay, infantile seizures, and B-cell lymphoma, in remission for approximately 3.5 years, was referred to the metabolic bone clinic for fractures and low bone mineral density. Array comparative genomic hybridization revealed a pathogenic microduplication in chromosome 7 at bands 7q21.3q22.1 that encompasses the SMURF1 gene. The clinical features of this child are congruous with the phenotype as ascribed excess Smurf1 mutations in mice. This is the first case description of osteoporosis in a child secondary to a microduplication involving SMURF1 gene.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Wu S, Liu Y, Zhang L, Han Y, Lin Y, Deng HW (2013) Genome-wide approaches for identifying genetic risk factors for osteoporosis. Genome Med 5(5):44. https://doi.org/10.1186/gm448
Yamashita M, Ying SX, Zhang GM, Li C, Cheng SY, Deng CX, Zhang YE (2005) Ubiquitin ligase Smurf1 controls osteoblast activity and bone homeostasis by targeting MEKK2 for degradation. Cell 121(1):101–113. https://doi.org/10.1016/j.cell.2005.01.035
Chan MC, Nguyen PH, Davis BN, Ohoka N, Hayashi H, Du K, Lagna G, Hata A (2007) A novel regulatory mechanism of the bone morphogenetic protein (BMP) signaling pathway involving the carboxyl-terminal tail domain of BMP type II receptor. Mol Cell Biol 27(16):5776–5789. https://doi.org/10.1128/MCB.00218-07
Blank M, Tang Y, Yamashita M, Burkett SS, Cheng SY, Zhang YE (2012) A tumor suppressor function of Smurf2 associated with controlling chromatin landscape and genome stability through RNF20. Nat Med 18(2):227–234. https://doi.org/10.1038/nm.2596
Koganti P, Levy-Cohen G, Blank M (2018) Smurfs in protein homeostasis, signaling, and cancer. Front Oncol 8:295. https://doi.org/10.3389/fonc.2018.00295
Nie J, Xie P, Liu L, Xing G, Chang Z, Yin Y, Tian C, He F, Zhang L (2010) Smad ubiquitylation regulatory factor 1/2 (Smurf1/2) promotes p53 degradation by stabilizing the E3 ligase MDM2. J Biol Chem 285(30):22818–22830. https://doi.org/10.1074/jbc.M110.126920
Wang M, Guo L, Wu Q, Zeng T, Lin Q, Qiao Y, Wang Q, Liu M, Zhang X, Ren L, Zhang S, Pei Y, Yin Z, Ding F, Wang HR (2014) ATR/Chk1/Smurf1 pathway determines cell fate after DNA damage by controlling RhoB abundance. Nat Commun 5:4901. https://doi.org/10.1038/ncomms5901
Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH (1999) A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400(6745):687–693. https://doi.org/10.1038/23293
Hightower HB, Robin NH, Mikhail FM, Ambalavanan N (2015) Array comparative genomic hybridisation testing in CHD. Cardiol Young 25(6):1155–1172. https://doi.org/10.1017/S1047951114001838
Godschalk MF, Downs RW (1988) Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Miner Res 3(1):113–115. https://doi.org/10.1002/jbmr.5650030117
Meeran K, Burrin JM, Noonan KA, Price CP, Ind PW (1995) A large volume spacer significantly reduces the effect of inhaled steroids on bone formation. Postgrad Med J 71(833):156–159. https://doi.org/10.1136/pgmj.71.833.156
Wu M, Chen G, Li YP (2016) TGF-beta and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res 4:16009. https://doi.org/10.1038/boneres.2016.9
Conflict of interest
We have no conflicts of interest to disclose.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Al-Rawi, R., Al-Beshri, A., Mikhail, F.M. et al. Fragile Bones Secondary to SMURF1 Gene Duplication. Calcif Tissue Int (2020). https://doi.org/10.1007/s00223-020-00668-5
- Dosage-sensitive gene